5-FU and 5-Bromouracil (1 mg/mL): 10 mg of pure powder of 5-FU was dissolved in 5 mL of Milli Q water and final volume was raised to 10 mL q.s, aliquoted and stored at −20 °C.
At the time of analysis, stock solutions were diluted with water to create spike-in working stock solutions containing 2, 5, 10, 20, 50, 100, and 200 μg/mL of 5-FU. To generate calibration standards, 950 μL of drug-free plasma were mixed with 50 μL of each spike-in from the working stock solution. This yielded the following concentrations: 0.10, 0.25, 0.50, 1.00, 2.50, 5.00, and 10.00 μg/mL. Comparably, four distinct concentrations (lower limit of quantification) of quality control samples were produced independently in blank plasma for 5-FU: LLOQ, 0.10 μg/mL; low-quality controls, 1 μg/mL; medium-quality controls, 2.5 μg/mL; and high-quality controls, 5 μg/mL. Samples of spiked plasma were all kept at −20 °C. The internal standard (I.S.) stock solution was made with a concentration of 1 mg/mL in water. I.S. working stock was further diluted with water and kept at −20 °C. Supplementary Materials and Procedures contain more information about preparing stocks.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.